摘要
生物标志物对于生命科学的研究发展,以及医学诊断、临床治疗和新药开发都具有重要意义,因而备受世界各国(地区)的关注,成为生物医学领域重要的研究热点。为此,不少国家(地区)都加大投入,建设生物标志物的数据平台等基础设施,同时出台相应的研究规划支持生物标志物相关基础研究的发展。与此同时,各跨国医药企业也对生物标志物及其相关应用的开发给予了高度关注,在知识产权方面开展前瞻性布局,并推动基础研究成果向终端产品的转化。为了全面透视国内外生物标志物的研发现状和趋势,从而为生物医学的基础研究以及相关产品的开发提供决策参考,有必要从情报研究的角度对国内外生物标志物的研究与应用进行分析。
Biomarkers have attracted widespread attention for great value in diagnostic, clinical and pharmaceutical researches, which have become an important research focus in pharmaceutical area. For this reason, many countries have been enhancing the networking infrastructures and policy instruments to promote progress of the basic research in this field. Meanwhile, a great number of companies are attaching high importance to biomarker research and its extensive application, patenting relative technologies to introduce them into industrial products. For a more systematic and comprehensive understanding of the development status and trend of biomarkers, this paper analyzed them from the point of intelligence research to give a decision-making reference to the basic research and product development in this area.
出处
《生命的化学》
CAS
CSCD
2013年第3期344-351,共8页
Chemistry of Life
